Developmental expression of major myelin protein genes in the CNS of X-linked hypomyelinating mutant rumpshaker

Mitchell, L. S., Gillespie, S. C., McAllister, F., Fanarraga, M. L., Kirkham, D., Kelly, B., Brophy, P. J., Griffiths, I. R., Montague, P. and Kennedy, P. G. E. (1992) Developmental expression of major myelin protein genes in the CNS of X-linked hypomyelinating mutant rumpshaker. Journal of Neuroscience Research, 33(2), pp. 205-217. (doi:10.1002/jnr.490330204)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1002/jnr.490330204

Abstract

Rumpshaker (rsh) is an X-linked mutation causing hypomyelination of the CNS of mice and has recently been identified as an allele of jimpy (jp). The mutation (known as jprsh) differs in several respects from other X-linked myelin mutants, including jp, in that mice have normal longevity, oligodendrocyte numbers are not decreased, and cell death is not a feature. Myelin sheaths are deficient in immunostainable PLP protein. The present study examines the developmental expression of the major myelin protein genes and translatability of PLP and MBP mRNA. Differences between the spinal cord and brain of mutants are evident in that mRNA levels are more markedly decreased in the brain. Protein levels are severely reduced in both locations and to a proportionately greater extent than the mRNA, particularly in the spinal cord where PLP RNA and protein are approximately 80% and 10–20%, respectively, of age-matched wild type mice. DM-20 protein, the other major product of the PLP gene, is disproportionately expressed in rumpshaker as is a 10 kDa proteolipid. In vitro translation studies indicate a marked decrease in PLP translation products from mutant RNA. There is no deficiency in the numbers of PLP mRNA-expressing oligodendrocytes although the abundance per cell is reduced. The data suggest that the phenotypic effects of the mutation may be associated with reduced translation of major myelin proteins, in particular PLP and its incorporation into compact myelin. However, the mutation is compatible with survival of oligodendrocytes and their differentiation to the stage of expressing PLP/DM-20 mRNA.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Brophy, Prof Peter and Montague, Dr Paul and Kennedy, Professor Peter and Griffiths, Prof Ian
Authors: Mitchell, L. S., Gillespie, S. C., McAllister, F., Fanarraga, M. L., Kirkham, D., Kelly, B., Brophy, P. J., Griffiths, I. R., Montague, P., and Kennedy, P. G. E.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Journal of Neuroscience Research
Publisher:Wiley
ISSN:0360-4012
ISSN (Online):1097-4547

University Staff: Request a correction | Enlighten Editors: Update this record